Skip to main content

Table 5 Tumor characteristics, dog responses, and survival for patients in Series II

From: Cancer odor in the blood of ovarian cancer patients: a retrospective study of detection by dogs during treatment, 3 and 6 months afterward

No

Test samples 3 m/6 m

Diagnosis date

Stage

Histopathology

Grade

3 months* Lotti Hanna

6 months* Lotti Hanna

Case record Jan 2013

1

4842/5095

Feb 2009

III/C

Seropapillary

2

O O

X #

Alive/relapse-free

2

3932/4799

June 2008

III/C

Seropapillary

3

O X

X X

Alive/relapse-free

3

406/1018

Nov 2005

III/C

Adenocarcinoma

3

X X

# X

Relapse 2008/Died 2009

4

9807/108

Jan 2005

II/C

Adenocarcinoma

2

O X

O #

Alive/relapse-free

5

8647/8955

Dec 2003

III/C

Clear cell

2

X X

O X

alive/relapse-free

6

10704/1328

Dec 2005

II/C

Seropapillary

3

# O

O #

Alive/relapse-free

7

451/1065

Sept 2005

III/C

Undifferentiated

4

X X

O #

Relapse 2009/alive

8

3835/6750

Feb 2000

III/C

Seropapillary

3

X X

X X

Relapse 2002/died 2005

9

6132/7872

Jan 2004

II/C

Seropapillary

2

X X

X X

Relapse 2006/alive

10

4926/5214

Aug 2008

II/B

Seropapillary

2

O #

X X

Alive/relapse-free

  1. * = all CA-125 values were <35UI.
  2. Dog responses:
  3. X = positive indication as cancer; O = no indication; # = uncertain indication.